Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
02/2007
02/14/2007EP1751131A1 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
02/14/2007EP1751124A2 Raf modulators and methods of use
02/14/2007EP1751116A2 Pyrimidine compounds and use thereof
02/14/2007EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
02/14/2007EP1750704A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
02/14/2007EP1750698A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
02/14/2007EP1668005B1 Acyloxymethylcarbamate prodrugs of oxazolidinones
02/14/2007EP1651640B1 Nicotinamide derivatives useful as pde4 inhibitors
02/14/2007EP1534391B1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
02/14/2007EP1532121B1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives
02/14/2007EP1370552B1 Rho-kinase inhibitors
02/14/2007EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors
02/14/2007EP1343757B1 Indole derivatives
02/14/2007CN1914224A HCV NS-3 serine protease inhibitors
02/14/2007CN1914184A Urea derivatives
02/14/2007CN1914179A Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
02/14/2007CN1914173A Quinolines useful in treating cardiovascular disease
02/14/2007CN1914170A Synthetic methodology for the reductive alkylation at the c-3 position of indoles
02/14/2007CN1913895A Novel M3 muscarinic acetylcholine receptor antagonists
02/14/2007CN1913886A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors
02/14/2007CN1913884A Substituted benzazoles and methods of their use as inhibitors of RAF kinase
02/14/2007CN1300114C Phenylpyridine carbonyl piperazine derivative
02/14/2007CN1300110C Hydroxamate derives useful as deacetylase inhibitors
02/14/2007CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
02/13/2007US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine
02/13/2007US7176316 Amino-piperidine derivatives
02/13/2007US7176307 Group 9 or 10 metal complexes of N-(N-heterocycle-substuted)acridines, phenoxazines and phenothiazines that are capable of converting a triplet excitation state into light emission and excellent in heat resistance; electronic devices with low power consumption
02/13/2007US7176306 Hydroxyalkyl cyclic diamine compound
02/13/2007US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
02/13/2007US7176235 10,11-Dehydroepothilones; anticancer, antiproliferative and antiarthritic agents
02/13/2007US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors
02/13/2007US7176225 For example, (6aR,7aS,8S,11aS)-5,8-bis(dimethylamino)-2-(2,2-diphenylvinyl)-9,11a,12-trihydroxy-11,13-dioxo-6,6a,7,7a,8,11,11a,13-octahydrotetraceno[2,1-d][1,3]oxazole-10-carboxamide; useful against antibiotic resistant organisms
02/13/2007US7176224 Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonists
02/13/2007US7176207 Anticoagulants; antithrombotic agents in the treatment and prevention of thrombosis
02/13/2007US7176200 Derivatives of sulphonamides, their preparation and use as medicaments
02/13/2007US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved
02/13/2007US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia
02/13/2007US7175958 Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same
02/13/2007CA2463976C N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
02/13/2007CA2276875C Insecticidal oxadiazine compounds
02/13/2007CA2265660C Process of production of 4-substituted-3-halogeno-1,4-benzoxazepine derivative and salts thereof
02/13/2007CA2122236C Quinolines and their analogs
02/13/2007CA2112420C N-arylhydrazine derivatives as insecticidal and acaricidal agents
02/08/2007WO2007016354A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
02/08/2007WO2007015533A1 Amidine compound and herbicide
02/08/2007WO2007014923A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007WO2007014920A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007WO2007014885A1 Antibacterial quinoline derivatives
02/08/2007WO2007014454A1 Ep4 receptor agonist, compositions and methods thereof
02/08/2007WO2006130613A3 Substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
02/08/2007WO2006126171A3 New antibiotic derivatives
02/08/2007WO2006123249A3 Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
02/08/2007WO2006113704A3 Subtituted heteroaryl cb1 antagonists
02/08/2007WO2006021420B1 Method for the production of diarylcycloalkyl derivatives
02/08/2007WO2005094329A3 Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor
02/08/2007US20070032664 Making intermediates such as ((4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-ethyl}-2-phenyl-[1,3]dioxan-4-yl)-acetic acid methyl ester for the synthesis of calcium atorvastatin (Lipitor(reg))
02/08/2007US20070032663 Intermediate in the synthesis of calcium atorvastatin (Lipitor(reg)) comprising an amine salt of a carboxylic acid, for example 2-(morpholinocarbonyl)ethylamine, phenylacetic acid salt
02/08/2007US20070032662 Novel process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrole-3-carboxylic acid and phenylamide
02/08/2007US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc.
02/08/2007US20070032528 inhibitors of vascular endothelial growth factor receptor tyrosine kinase; antiproliferative agents; antitumor; 4-Hydroxy-3-(5-methylbenzimidazol-2-yl)hydropyridino[3,4-b]pyridin-2-one; nitrogen containing cyclic compounds
02/08/2007US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
02/08/2007US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia
02/08/2007US20070032508 Quinazoline derivatives as tyrosine kinase inhibitors
02/08/2007US20070032500 Therapeutic agents useful for treating pain
02/08/2007US20070032497 Fused-ring compounds and use thereof as drugs
02/08/2007US20070032492 Cytokine Inhibitors
02/08/2007US20070032490 N-Phenyl-'(4-pyridyl)-azinyl!amine derivatives as plant protection agents
02/08/2007US20070032489 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
02/08/2007US20070032488 6-Membered aryl and heteroaryl derivatives for treating viruses
02/08/2007US20070032484 Cathepsin K inhibitors
02/08/2007US20070032483 Process for the production of mycophenolate mofetil
02/08/2007US20070032482 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
02/08/2007US20070032478 Thiophene-2-carboxylic acid (4-{3-[(4-morpholin-4-yl-phenylamino)-methylene]-2-oxo-2,3-dihydro-1H-indole-6-carbonyl}-phenyl)-amide for modulating tyrosine kinase signal transduction to regulate, modulate and/or inhibit abnormal cell proliferation
02/08/2007US20070032474 Use of a compound of formula 1 for making a pharmaceutical composition
02/08/2007US20070032472 Reacting a 4-morpholinyl aniline with R-epichlorohydrin; carbonylating to form (a chloromethyloxazolidinone; reacting with potassium phthalimide or aziding; forming free amine with hydrazine hydate, which may be amidated with acetic anhydride; oxazolidinone and 3-chloro-2-hydroxypropyl intermediates
02/08/2007US20070032466 Drug containing chymase inhibitor as the active ingredient
02/08/2007US20070028961 Organic dye compositions and use thereof in photovoltaic cells
02/08/2007DE102005035575A1 New heteroaryl derivatives are phosphodiesterase-4 enzyme inhibitors useful for the treatment of e.g. respiratory or gastrointestinal complaints or diseases, depression, Alzheimer's disease and Parkinson's disease
02/08/2007CA2617099A1 Macrocyclic inhibitors of hepatitis c virus
02/08/2007CA2616604A1 Ep4 receptor agonist, compositions and methods thereof
02/08/2007CA2615900A1 Quinoline derivatives as antibacterial agents
02/08/2007CA2615574A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
02/08/2007CA2614981A1 Antibacterial quinoline derivatives
02/07/2007EP1749827A1 Anti-tumor agent
02/07/2007EP1749003A1 Compounds and compositions as ppar modulators
02/07/2007EP1749001A1 3-piperidinylisochroman-5-ols as dopamine agonists
02/07/2007EP1749000A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
02/07/2007EP1748997A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs
02/07/2007EP1748987A2 2-propene-1-ones as hsp 70 inducers
02/07/2007EP1748985A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
02/07/2007EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists
02/07/2007EP1748755A1 M-phenylene diamine coupler components
02/07/2007EP1670773B1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
02/07/2007EP1651622B1 Process for the preparation of 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds
02/07/2007EP1421079B1 Thiophenyl compounds as medicaments
02/07/2007CN1910177A Substituted quinolines and their use as mycobacterial inhibitors
02/07/2007CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
02/07/2007CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
02/07/2007CN1910172A 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines
02/07/2007CN1910159A 2,4-diaminopyrimidines and their use for inducing cardiomyogenesis